China
Chinese court dismisses Weixin claim against OUE Lippo
The Wuxi Xinwu District Court held that a 2015 land transfer between Wuxi Yilin and Wuxi New District Phoenix Hospital was legal.
Chinese court dismisses Weixin claim against OUE Lippo
The Wuxi Xinwu District Court held that a 2015 land transfer between Wuxi Yilin and Wuxi New District Phoenix Hospital was legal.
Britain's AstraZeneca invests $1b in Chinese life sciences parks
It will also boost the headcount in its Shanghai R&D centre to 1,000.
Top Chinese drug distributors grapple with tepid margins
Blame the two-invoice system.
Chinese pharmas face price pressures from Indian entrants under GPO
The entrance of Indian players may cut prices further by 30%.
Chinese pharma sales to hit $268b by 2028: Fitch Solutions
The effects of regulatory change on the sales of patented medicine are expected to be mild.
VC-sourced healthcare funding in Asia fell 39% to $2.57b in Q2
China-based Weimai’s $155m funding round was one of the quarter’s notable deals.
China healthtech funding crashed 49% to $1.92b in H1
The number of deals fell to 62 transactions in the same period.
Cell therapy in the Asia Pacific — solution to the cancer challenge?
Over the next decade, an estimated $2t investment into Universal Health Coverage (UHC) schemes is expected to land in Asia. The developing markets in the region have traditionally under-funded healthcare at a rate of about 5% of GDP (compared to the average of 12% in OECD countries like Australia and Japan). Whilst some emerging markets in Asia continue to grapple with lingering infection control, all are shifting focus to the more advanced lifestyle diseases.
Chinese healthcare revenue growth set to weaken
The plan by the State Council to cut high-value medical consumables prices deals a heavy blow.
New York-listed New Frontier to buy China's United Family Healthcare for $1.44b
UFH is expected to be given the exclusive right to manage New Frontier Group’s 64,000 sqm flagship Shenzhen city center hospital.
China's healthcare service sector's revenue to hit $1.16t by 2020
Tech giants such as Ping An and Tencent are tapping into blockchain and AI to address the sector’s talent shortage.
Chinese drugmakers' revenue could be dragged by stricter regulatory oversight
This follows the accounting scandal of a pharmaceutical firm accused of fabricating revenue and costs.
China's medical device imports to continue slump in 2019-2020
The 25% hike imposed in 2018 have resulted in a sharp fall in imports of MRI systems, X-ray apparatus, patient monitors and ophthalmic instruments from the US.
APAC's medical device markets to be further hit by tighter regulations and pricing controls
Medical device approvals in China plunged 38% in 2018 to 5,528 successful registrations.
China's retail pharmacies could bow out to GPO drug prices
The State Medical Insurance Administration is set to roll out its new NRDL and price negotiation list in June.
Government reforms to boost China's pharmaceutical sector: report
The sector is described to be “one of the most attractive investment destinations in the Asia Pacific region”.
Price cuts intensify as China's GPO programme expands outside 11 cities
Drugs with two or more bioequivalence qualifiers are likely to face fierce price competition.
Most Read
1. NUH to establish health centre for early cancer detection in 2025 2. MSD navigates the pandemic tapestry in COVID-19 fight 3. IHH Healthcare adopts new data platform for modernised healthcare 4. Singapore launches new centre for enhanced pain management 5. KPMG's Guillaume Sachet on navigating healthcare’s evolution: Cross-border collaboration crucial to fostering trusted AI, innovationResource Center
Read Here
Advertise
Sign Up
Event News
Event News
KPMG's Guillaume Sachet on navigating healthcare’s evolution: Cross-border collaboration crucial to fostering trusted AI, innovation
![KPMG's Guillaume Sachet on navigating healthcare’s evolution: Cross-border collaboration crucial to fostering trusted AI, innovation]()
Co-Written / Partner
Sachet recommended healthcare organisations collaborate, learn from partners outside healthcare, and be bold to embrace new trends.
Sachet recommended healthcare organisations collaborate, learn from partners outside healthcare, and be bold to embrace new trends.
